These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10389025)

  • 21. Antioxidants, pro-oxidants, and their effects.
    Herbert V
    JAMA; 1994 Dec; 272(21):1659-60. PubMed ID: 7966891
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of antioxidants for the correction of coronary risk factors in patients with myocardial ischemia].
    Derbeneva SA; Pogozheva AV; Vasil'ev AV; Akol'zina SE; Lysikova SL
    Vopr Pitan; 2003; 72(4):17-20. PubMed ID: 12968298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women.
    Kushi LH; Folsom AR; Prineas RJ; Mink PJ; Wu Y; Bostick RM
    N Engl J Med; 1996 May; 334(18):1156-62. PubMed ID: 8602181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.
    Houston MC
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antioxidant vitamin supplementation in the prevention of cardiovascular disease].
    Yuen B; Furrer L; Ballmer PE
    Ther Umsch; 2005 Sep; 62(9):615-8. PubMed ID: 16218497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E use in preventing coronary heart disease in patients undergoing dialysis.
    Rein J
    Mayo Clin Proc; 2002 Mar; 77(3):295. PubMed ID: 11888036
    [No Abstract]   [Full Text] [Related]  

  • 27. Antioxidant vitamins in atherosclerosis--animal experiments and clinical studies.
    Ozkanlar S; Akcay F
    Adv Clin Exp Med; 2012; 21(1):115-23. PubMed ID: 23214308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperlipidaemia and cardiovascular disease.
    Stone NJ
    Curr Opin Lipidol; 2004 Dec; 15(6):707-9. PubMed ID: 15529032
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vitamin E for prevention of arteriosclerosis, coronary heart disease and cancer. Antioxidants--what is their value? Minerals, Vitamins & Co. Series, 6: Beta-carotene, vitamin C and E].
    Pannewig K
    Fortschr Med; 1998 Oct; 116(29):61-2. PubMed ID: 9846478
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of atherosclerosis. The potential role of antioxidants.
    Mehra MR; Lavie CJ; Ventura HO; Milani RV
    Postgrad Med; 1995 Jul; 98(1):175-6, 179-84. PubMed ID: 7603945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre.
    Bolton-Smith C; Woodward M; Tunstall-Pedoe H
    Eur J Clin Nutr; 1992 Feb; 46(2):85-93. PubMed ID: 1313760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antioxidant efficacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial.
    Singhal S; Gupta R; Goyle A
    J Assoc Physicians India; 2001 Mar; 49():327-31. PubMed ID: 11291971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension.
    Houston MC
    Prog Cardiovasc Dis; 2005; 47(6):396-449. PubMed ID: 16115519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vitamins and microelements in patients with chronic kidney disease].
    Małgorzewicz S; Jankowska M; Kaczkan M; Czajka B; Rutkowski B
    Wiad Lek; 2014; 67(1):33-8. PubMed ID: 25782215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SU.VI.MAX trial on antioxidants.
    Hercberg S; Galan P; Preziosi P; Malvy M; Briançon S; Ait HM; Rahim B; Favier A
    IARC Sci Publ; 2002; 156():451-5. PubMed ID: 12484233
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease].
    Cullen P; Assmann G
    Dtsch Med Wochenschr; 2000 Jul; 125(28-29):881-7. PubMed ID: 10943220
    [No Abstract]   [Full Text] [Related]  

  • 37. A high menaquinone intake reduces the incidence of coronary heart disease.
    Gast GC; de Roos NM; Sluijs I; Bots ML; Beulens JW; Geleijnse JM; Witteman JC; Grobbee DE; Peeters PH; van der Schouw YT
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):504-10. PubMed ID: 19179058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidative vitamins in prevention of ischemia/reperfusion injury.
    Nagel E; Meyer zu Vilsendorf A; Bartels M; Pichlmayr R
    Int J Vitam Nutr Res; 1997; 67(5):298-306. PubMed ID: 9350470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antioxidants and atherosclerosis. What is certain in primary and secondary prevention?].
    Laule M; Stangl V; Stangl K
    Med Monatsschr Pharm; 2004 Nov; 27(11):379-86. PubMed ID: 15566233
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.
    Brown BG; Zhao XQ; Chait A; Frohlich J; Cheung M; Heise N; Dowdy A; DeAngelis D; Fisher LD; Albers J
    Can J Cardiol; 1998 Apr; 14 Suppl A():6A-13A. PubMed ID: 9594927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.